






Business Directories by State
































Locations

            Top States:

                Florida
- (7,668,567 Businesses)
California
- (7,998,710 Businesses)
Texas
- (4,844,128 Businesses)
New York
- (4,451,438 Businesses)
Pennsylvania
- (1,273,348 Businesses)

Advertisements









States












                                                        Alabama
                                                    




                                                        424,733 Companies Found
                                                    


                                                        529,179 People Found
                                                    










                                                        Alaska
                                                    




                                                        90,124 Companies Found
                                                    


                                                        119,266 People Found
                                                    










                                                        Arizona
                                                    




                                                        757,577 Companies Found
                                                    


                                                        800,057 People Found
                                                    










                                                        Arkansas
                                                    




                                                        263,265 Companies Found
                                                    


                                                        325,844 People Found
                                                    










                                                        California
                                                    




                                                        7,998,710 Companies Found
                                                    


                                                        7,373,821 People Found
                                                    










                                                        Colorado
                                                    




                                                        810,965 Companies Found
                                                    


                                                        814,457 People Found
                                                    










                                                        Connecticut
                                                    




                                                        468,528 Companies Found
                                                    


                                                        572,167 People Found
                                                    










                                                        Delaware
                                                    




                                                        132,203 Companies Found
                                                    


                                                        114,760 People Found
                                                    










                                                        District Of Columbia
                                                    




                                                        101,098 Companies Found
                                                    


                                                        225,569 People Found
                                                    










                                                        Florida
                                                    




                                                        7,668,567 Companies Found
                                                    


                                                        10,379,297 People Found
                                                    










                                                        Georgia
                                                    




                                                        1,255,912 Companies Found
                                                    


                                                        1,396,340 People Found
                                                    










                                                        Hawaii
                                                    




                                                        129,778 Companies Found
                                                    


                                                        152,776 People Found
                                                    










                                                        Idaho
                                                    




                                                        172,946 Companies Found
                                                    


                                                        201,511 People Found
                                                    










                                                        Illinois
                                                    




                                                        1,181,775 Companies Found
                                                    


                                                        1,483,850 People Found
                                                    










                                                        Indiana
                                                    




                                                        578,336 Companies Found
                                                    


                                                        719,895 People Found
                                                    










                                                        Iowa
                                                    




                                                        329,478 Companies Found
                                                    


                                                        460,060 People Found
                                                    










                                                        Kansas
                                                    




                                                        282,167 Companies Found
                                                    


                                                        348,203 People Found
                                                    










                                                        Kentucky
                                                    




                                                        405,363 Companies Found
                                                    


                                                        504,609 People Found
                                                    










                                                        Louisiana
                                                    




                                                        633,706 Companies Found
                                                    


                                                        615,567 People Found
                                                    










                                                        Maine
                                                    




                                                        130,772 Companies Found
                                                    


                                                        174,828 People Found
                                                    










                                                        Maryland
                                                    




                                                        674,762 Companies Found
                                                    


                                                        710,572 People Found
                                                    










                                                        Massachusetts
                                                    




                                                        726,390 Companies Found
                                                    


                                                        1,027,523 People Found
                                                    










                                                        Michigan
                                                    




                                                        934,309 Companies Found
                                                    


                                                        1,131,011 People Found
                                                    










                                                        Minnesota
                                                    




                                                        592,078 Companies Found
                                                    


                                                        758,209 People Found
                                                    










                                                        Mississippi
                                                    




                                                        261,251 Companies Found
                                                    


                                                        322,667 People Found
                                                    










                                                        Missouri
                                                    




                                                        597,997 Companies Found
                                                    


                                                        706,322 People Found
                                                    














                                                        Montana
                                                    




                                                        130,347 Companies Found
                                                    


                                                        158,428 People Found
                                                    










                                                        Nebraska
                                                    




                                                        191,594 Companies Found
                                                    


                                                        279,673 People Found
                                                    










                                                        Nevada
                                                    




                                                        1,037,013 Companies Found
                                                    


                                                        1,194,142 People Found
                                                    










                                                        New Hampshire
                                                    




                                                        154,616 Companies Found
                                                    


                                                        193,717 People Found
                                                    










                                                        New Jersey
                                                    




                                                        974,361 Companies Found
                                                    


                                                        1,091,903 People Found
                                                    










                                                        New Mexico
                                                    




                                                        178,355 Companies Found
                                                    


                                                        231,696 People Found
                                                    










                                                        New York
                                                    




                                                        4,451,438 Companies Found
                                                    


                                                        2,890,348 People Found
                                                    










                                                        North Carolina
                                                    




                                                        989,345 Companies Found
                                                    


                                                        1,123,726 People Found
                                                    










                                                        North Dakota
                                                    




                                                        81,418 Companies Found
                                                    


                                                        101,993 People Found
                                                    










                                                        Ohio
                                                    




                                                        1,062,591 Companies Found
                                                    


                                                        1,335,493 People Found
                                                    










                                                        Oklahoma
                                                    




                                                        379,566 Companies Found
                                                    


                                                        422,307 People Found
                                                    










                                                        Oregon
                                                    




                                                        510,731 Companies Found
                                                    


                                                        621,776 People Found
                                                    










                                                        Pennsylvania
                                                    




                                                        1,273,348 Companies Found
                                                    


                                                        1,546,221 People Found
                                                    










                                                        Puerto Rico
                                                    




                                                        55,527 Companies Found
                                                    


                                                        60,845 People Found
                                                    










                                                        Rhode Island
                                                    




                                                        111,772 Companies Found
                                                    


                                                        132,878 People Found
                                                    










                                                        South Carolina
                                                    




                                                        406,911 Companies Found
                                                    


                                                        483,894 People Found
                                                    










                                                        South Dakota
                                                    




                                                        92,785 Companies Found
                                                    


                                                        126,265 People Found
                                                    










                                                        Tennessee
                                                    




                                                        620,250 Companies Found
                                                    


                                                        751,954 People Found
                                                    










                                                        Texas
                                                    




                                                        4,844,128 Companies Found
                                                    


                                                        5,747,622 People Found
                                                    










                                                        Utah
                                                    




                                                        363,011 Companies Found
                                                    


                                                        377,419 People Found
                                                    










                                                        Vermont
                                                    




                                                        81,906 Companies Found
                                                    


                                                        106,956 People Found
                                                    










                                                        Virginia
                                                    




                                                        911,909 Companies Found
                                                    


                                                        1,016,492 People Found
                                                    










                                                        Washington
                                                    




                                                        830,492 Companies Found
                                                    


                                                        864,073 People Found
                                                    










                                                        West Virginia
                                                    




                                                        136,960 Companies Found
                                                    


                                                        185,319 People Found
                                                    










                                                        Wisconsin
                                                    




                                                        486,944 Companies Found
                                                    


                                                        707,971 People Found
                                                    










                                                        Wyoming
                                                    




                                                        77,247 Companies Found
                                                    


                                                        90,781 People Found
                                                    













                Company Directory:
            
            Browse directory by company name:
            
A
B
C
D
E
F
G
H
I
J
K
L
M
N
O
P
Q
R
S
T
U
V
W
X
Y
Z
(more)







People Directory: 

            Names starting with letters:

            
A
B
C
D
E
F
G
H
I
J
K
L
M
N
O
P
Q
R
S
T
U
V
W
X
Y
Z
















You must be signed in to print.
Once signed in, look for the PDF button.











    Randall Schatzman | Alder Biopharmaceuticals Inc | ZoomInfo.com










 




Randall C. Schatzman Ph.D.: Executive Profile & Biography - Bloomberg









































  





















































































July 28, 2017 2:09 PM ET
Biotechnology

Company Overview of Alder Biopharmaceuticals, Inc.



SnapshotPeople 




OverviewBoard MembersCommittees



Executive Profile
Randall C. Schatzman Ph.D.Co-Founder, Chief Executive Officer, President and Director, Alder Biopharmaceuticals, Inc.AgeTotal Calculated CompensationThis person is connected to 2 Board Members in 2 different organizations across 2 different industries.See Board Relationships62$4,036,750As of Fiscal Year 2016
Background

		Dr. Randall C. Schatzman, PhD, co-founded Alder Biopharmaceuticals Inc. in May 2002 and has been its Chief Executive Officer and President since May 2002. Dr. Schatzman served as Senior Vice President of Discovery Research at Celltech R&D Inc., where he led a group of 95 scientists responsible for much of the therapeutic antibody pipeline for Celltech. Prior to Celltech, he served as a Director of Gene Discovery at Mercator Genetics helping to solve the gene responsible ... for hereditary hemochromatosis and advancing the Del-1 angiogenesis factor into preclinical models and partnering Del-1 with Valentis. Prior to Mercator, he was at Syntex/Roche Bioscience where he helped found the Cancer and Developmental Biology Institute and served as Preclinical Team Leader for Cytovene and Team Leader for Valcyte and was responsible for preclinical studies on Cellcept. He serves as a Member of Advisory Board of Immusoft Corporation. He has been Director of Alder Biopharmaceuticals Inc. since January 2004. He received his Ph.D. in Molecular Pharmacology from Emory University before completed an American Cancer Society postdoctoral fellowship in the laboratory of J. Michael Bishop at the University of California, San Francisco.Read Full Background




Corporate Headquarters
11804 North Creek Parkway SouthBothell, Washington 98011United StatesPhone: 425-205-2900Fax: 425-205-2901
Board Members Memberships
2004-PresentCo-Founder, Chief Executive Officer, President and DirectorAlder Biopharmaceuticals, Inc.
Education
PhD Emory UniversityBS Purdue University
Other Affiliations
Emory UniversityPurdue UniversityImmusoft Corporation


Annual Compensation
Salary$525,000Total Annual Compensation$525,000
Stocks Options
All Other Compensation$34,311Exercised Options$108,181Exercised Options Value$3,042,695Exercisable Options$633,113Exercisable Options Value$9,128,862Unexercisable Options$375,210Unexercisable Options Value$571,388Total Value of Options$12,742,945Total Number of Options$1,116,504
Total Compensation
Total Annual Cash Compensation$833,624Total Short Term Compensation$525,000Other Long Term Compensation$34,311Total Calculated Compensation$4,036,750




Request Profile Update
















 












The information and data displayed in this profile are created and managed by S&P Global Market Intelligence, a division of S&P Global. Bloomberg.com does not create or control the content. For inquiries, please contact S&P Global Market Intelligence directly by clicking 
	here.




Stock Quotes


Market data is delayed at least 15 minutes.







Company Lookup



COMPETITOR COMPENSATIONThere is no Competitor Compensation data available.










Sponsored Financial Commentaries

Sponsored Links






Browse Companies
A
B
C
D
E
F
G
H
I
J
K
L
M
N
O
P
Q
R
S
T
U
V
W
X
Y
Z
 | 
0
1
2
3
4
5
6
7
8
9






Request Profile Update

						Only a company representative may request an update for the company profile. Documentation will be required.
					  
To contact Alder Biopharmaceuticals, Inc., please visit .  Company data is provided by S&P Global Market Intelligence.  Please use this form to report any data issues.
					  


Information Missing - Please enter your information in the following field(s): 




Company Name

Your Name*

Your E-Mail Address*

Your Phone Number*

Type of Data*


Overview
Executives
Key developments
Similar companies
Transactions


Update Needed*

All data changes require verification from public sources.  Please include the correct value or values and a source where we can verify.


Cancel


Submit






Your requested update has been submitted
Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.


Close




























Bizapedia.com - Human Validation
















COMPANIESPEOPLEPRODUCTS/SERVICESTRADEMARKSADDRESSESPHONE BOOK




            Our system has detected a high number of page requests from your IP Address, please prove to us that you are a human to continue using our website.
        
























                            Please send me to the search subscription offer page after I successfully answer the word challenge.
                        









BIZAPEDIAPRO SEARCHPerform unlimited searches via ouradvanced search form withBizapedia Pro Search.FIND OUT MORE >BIZAPEDIAPRO DATABuild custom data listsfor one or many stateswith Bizapedia Pro Data.FIND OUT MORE >


Copyright © 2012-2017 · Bizapedia.com · All rights reserved.BlogPro SearchPro APIContact UsTerms of UsePrivacy PolicySitemapDesktop Version





















Randall C. Schatzman Ph.D. - Executive Bio, Compensation History, and Contacts - Equilar Atlas










 

















Log in | Sign up








x

 






As Featured In



















Randall C. Schatzman Ph.D.
Dir., President and Chief Executive Officer at Alder Biopharmaceuticals, Inc.


View Full Profile
Are you Randall C. Schatzman Ph.D.? Claim your profile


 


Sign up for Equilar Atlas and view Randall C. Schatzman Ph.D.'s full profile. 
With Equilar Atlas, you can:



IDENTIFY corporate executives in Randall C. Schatzman Ph.D.'s  network and community.
												FOLLOW changes in Randall C. Schatzman Ph.D.'s employment and money-in-motion.
												CONNECT with Randall C. Schatzman Ph.D. through your network of contacts.
												








Randall C. Schatzman Ph.D.'s Executive Work History


Current


Dir., President and Chief Executive Officer, 
Alder Biopharmaceuticals, Inc.


Past
To view Randall C. Schatzman Ph.D.'s complete executive work history, sign up now
Age
62

 
 


Randall C. Schatzman Ph.D.'s Biography



Dr. Schatzman has served as our President, Chief Executive Officer and director since he co-founded the Company, which commenced operations in January 2004. From 1999 to 2004, Dr. Schatzman served as Senior Vice President of Discovery Research at Celltech R&D, Inc., a wholly-owned subsidiary of Celltech Group plc, a biopharmaceutical company, where he led a group of scientists responsible for much of the therapeutic antibody pipeline for Celltech. From 1995 to 1999, Dr. Schatzman served as Director of Gene Discovery at Mercator Genetics Inc., a genomics company. From 1987 to 1995, Dr. Schatzman served as Section Leader at Roche Bioscience, pr ...
(Read More)

			Dr. Schatzman has served as our President, Chief Executive Officer and director since he co-founded the Company, which commenced operations in January 2004. From 1999 to 2004, Dr. Schatzman served as Senior Vice President of Discovery Research at Celltech R&D, Inc., a wholly-owned subsidiary of Celltech Group plc, a biopharmaceutical company, where he led a group of scientists responsible for much of the therapeutic antibody pipeline for Celltech. From 1995 to 1999, Dr. Schatzman served as Director of Gene Discovery at Mercator Genetics Inc., a genomics company. From 1987 to 1995, Dr. Schatzman served as Section Leader at Roche Bioscience, previously Syntex Corp., a subsidiary of Roche Holdings Ltd., a biotechnology company, where he helped found the Cancer and Developmental Biology Institute. Dr. Schatzman holds a Ph.D. in Molecular Pharmacology from Emory University and a B.S. in Biochemistry from Purdue University.     The Nominating and Corporate Governance Committee believes that Dr. Schatzman is qualified to serve on our Board of Directors due to his extensive knowledge of our company and his extensive background in the biotechnology industry.
		
Source: Alder Biopharmaceuticals, Inc. on 04/28/2017
		
	

 






Sign up for Equilar Atlas and view Randall C. Schatzman Ph.D.'s full profile. 



												By accessing Equilar Atlas, you can view bios, network, salary and wealth events
												of industry-leading executives like Randall C. Schatzman Ph.D.. More specifically, you'll be able to:
												

IDENTIFY corporate executives in Randall C. Schatzman Ph.D.'s  network and community.
												FOLLOW changes in Randall C. Schatzman Ph.D.'s employment and money-in-motion.
												CONNECT with Randall C. Schatzman Ph.D. through your network of conections.
												




View Full Profile


 








Search for over 360,000 executive profiles.





/bio



													Example: Randall C. Schatzman Ph.D.


















Randall C. Schatzman Ph.D.'s Connections (17)





Sign up now to view Randall C. Schatzman Ph.D.'s 17 connections »









Clay B. Siegall
President, Chief Executive Officer and Chairman of the Board, Seattle Genetics, Inc.









Elisabeth A. Sandoval
Chief Commercial Officer, Alder Biopharmaceuticals, Inc.









Alan B. Montgomery
Board Member, Alder Biopharmaceuticals, Inc.









Mark J. Litton
Chief Business Officer, Treasurer and Secretary, Alder Biopharmaceuticals, Inc.









Deepika R. Pakianathan
Former Board Member, Alder Biopharmaceuticals, Inc.









Jeffrey T. Smith
Senior Vice President, Translational Medicine, Alder Biopharmaceuticals, Inc.









John A. Latham
Chief Scientific Officer, Alder Biopharmaceuticals, Inc.









Larry K. Benedict
Executive Vice President, Principal Accounting Officer and Principal Financial Officer, Alder Biopharmaceuticals, Inc.









Stephen M. Dow
Former Chairman of the Board, Alder Biopharmaceuticals, Inc.









Timothy M. Whitaker
Chief Medical Officer, Alder Biopharmaceuticals, Inc.








Popular Profiles






														Sign up now to view more executive profiles »
														









Thomas J. Lynch
Executive Chairman, TE Connectivity Ltd.









John J. Kita
EVP and CFO, A. O. Smith









Carl G. Annessa
EVP and COO, Hornbeck Offshore Services, Inc.









Elon R. Musk
CEO and Chairman, Tesla









Michael C. Montgomery
Board Member, NMI Holdings, Inc.












×

Claim Your Profile Coming Soon
Interested in updating your biography and work history?
We're working on making it happen.
We'll email you when this feature is available.
Please enter valid email address.

Done


Thank you for your interest.
Ok






			Browse executive profiles:
			
				 A
			
				 B
			
				 C
			
				 D
			
				 E
			
				 F
			
				 G
			
				 H
			
				 I
			
				 J
			
				 K
			
				 L
			
				 M
			
				 N
			
				 O
			
				 P
			
				 Q
			
				 R
			
				 S
			
				 T
			
				 U
			
				 V
			
				 W
			
				 X
			
				 Y
			
				 Z



Equilar Homepage
Equilar Atlas
Equilar Insight
Equilar BoardEdge
Equilar Engage
Research Services
Knowledge Network
About Us
Login

ï¿½ 2017 Equilar All Rights Reserved. Privacy Policy
1100 Marshall Street, Redwood City, CA 94063 | Phone (650) 241-6600 | Fax (650) 701-0993




























Schatzman, Randall

NameAgeState
Randall C Schatzman62 WA


FIND MORE PEOPLE


First Name



MI



Last Name




State

All States
Alabama
Alaska
Arizona
Arkansas
California
Colorado
Connecticut
Delaware
Florida
Georgia
Hawaii
Idaho
Illinois
Indiana
Iowa
Kansas
Kentucky
Louisiana
Maine
Maryland
Massachusetts
Michigan
Minnesota
Mississippi
Missouri
Montana
Nebraska
Nevada
New Hampshire
New Jersey
New Mexico
New York
North Carolina
North Dakota
Ohio
Oklahoma
Oregon
Pennsylvania
Puerto Rico
Rhode Island
South Carolina
South Dakota
Tennessee
Texas
Utah
Vermont
Virginia
Washington
Washington D.C.
West Virginia
Wisconsin
Wyoming



 


I entered a partial first name above







PHONE NUMBER SEARCH


 (ex. 555-555-5555)



 


 

Randall  Schatzman at InstantPeopleFinder.com
Find information on Randall  Schatzman instantly.


Help | Contact Us | FAQs | Terms & Conditions
Copyright © 2003-2017, LookupAnyone
 




 




Leadership Team - Alder Biopharmaceuticals



































 























 
Leadership Team






Leadership Team





Randall C. Schatzman, Ph.D.
President and Chief Executive Officer
Dr. Schatzman has served as our President, Chief Executive Officer and director since he co-founded the company, which commenced operations in January 2004. From 1999 to 2004, Dr. Schatzman served as Senior Vice President of Discovery Research at Celltech R&D, Inc., a wholly owned subsidiary of Celltech Group plc, a biopharmaceutical company, where he led a group of scientists responsible for much of the therapeutic antibody pipeline for Celltech. From 1995 to 1999, Dr. Schatzman served as Director of Gene Discovery at Mercator Genetics Inc., a genomics company. From 1987 to 1995, Dr. Schatzman served as Section Leader at Roche Bioscience, previously Syntex Corp., a subsidiary of Roche Holdings Ltd., a biotechnology company, where he helped found the Cancer and Developmental Biology Institute. Dr. Schatzman holds a Ph.D. in Molecular Pharmacology from Emory University and a B.S. in Biochemistry from Purdue University.

John A. Latham, Ph.D.
Chief Scientific Officer
Dr. Latham has served as our Chief Scientific Officer since co-founding Alder BioPharmaceuticals in January 2004.From 1998 to 2004, Dr. Latham served as a director, senior director, and most recently as Vice President of Gene Function and Target Validation for Celltech Group plc. In 1994, Dr. Latham joined Darwin Molecular Corporation, a first-generation gene-to-drug biotechnology company, as a founding director, where he served from 1994 to 1998. Dr. Latham was one of the early scientists hired by Gilead Sciences, Inc., a biopharmaceutical company, and, from 1989 to 1994, he was a member of a core group established to exploit novel oligonucleotide-based technologies. Dr. Latham holds a Ph.D. in Biochemistry from Massachusetts Institute of Technology and a B.S. in Chemistry from Colorado State University.

Mark J. Litton, Ph.D., MBA
Chief Business Officer and Treasurer
Dr. Litton has served as our Chief Business Officer, Treasurer and Secretary since co-founding the company in January 2004. From 1999 to 2004, Dr. Litton served as Vice President of Business Development for Celltech Group, where he was responsible for securing, commercializing and partnering numerous novel discoveries and therapeutic opportunities. In 1999, Dr. Litton joined Celltech Group as an employee of Chiroscience Group plc and was later promoted to Vice President Business Development after Chiroscience’s merger with Celltech Group in 1999. From 1997 to 1999, Dr. Litton served as the Manager of Business Development for Ribozyme Pharmaceuticals Inc., currently Sirna Therapeutics, Inc., a biopharmaceutical company, where he helped form relationships with Eli Lilly and Company, Roche Bioscience and GlaxoWellcome plc, currently GlaxoSmithKline plc, a biopharmaceutical company. From 1991 to 1994, Dr. Litton served as a research associate for DNAX Research Institute, a research facility of Schering-Plough, now Merck & Co., a publicly traded pharmaceutical company. Dr. Litton holds a Ph.D. in Immunology from Stockholm University, an M.B.A. from Santa Clara University and a B.S. in Biochemistry from the University of California, Santa Cruz.

Jeffrey T.L. Smith, M.D., FRCP
Senior Vice President, Translational Medicine
Dr. Smith has served as our Senior Vice President, Translational Medicine since 2012 and served in other senior management positions from April 2004 to 2012.From 1999 to 2004, Dr. Smith served as Senior Director of Medical Research for Celltech R&D, where he was responsible for planning and managing the CDP870 anti-TNF clinical trials for RA as well as several other key autoimmune clinical development programs. From 1997 to 1999, Dr. Smith served as Medical Director at Simbec Research Ltd., a contract research organization. From 1995 to 1997, Dr. Smith served as Head of Clinical Pharmacology at Hoechst Marion Roussel Ltd., a pharmaceutical company. From 1994 to 1995, Dr. Smith served as a Senior Clinical Physician at the Proctor and Gamble Company, a publicly-traded consumer products company, and from 1989 to 1994, he served as a Senior Research Physician in the clinical pharmacology department at Glaxo Research and Development Ltd., now a division of GlaxoSmithKline plc, a healthcare company. Dr. Smith holds an M.D. from the University of London and is a Fellow of the Royal College of Physicians in London.
Elisabeth A. Sandoval, MBA
Chief Commercial Officer
Ms. Sandoval has served as our Chief Commercial Officer since September 2016.From 2012 to 2015, Ms. Sandoval served as the Chief Commercial Officer for Kythera Biopharmaceuticals. From 2010 to 2012, she served as Vice President of Global Marketing and Strategy at Bausch + Lomb Surgical. From 1988 to 2010, she held roles of increasing responsibility at Allergan including Global Vice President, Strategic Marketing and Senior Director of Global Strategic Marketing, which included sales management and marketing leadership for multiple products including Botox® for neurological and other disorders. She began her career in research and development at Johnson & Johnson’s Ethicon division. She holds an MBA from Pepperdine University and a B.S. in Biology from the University of California, Irvine.
Timothy M. Whitaker, M.D. 
Chief Medical Officer
Dr. Whitaker has served as our Chief Medical Officer since June 2016.From 2004 to 2016, Dr. Whitaker held positions of increasing responsibility at Shire Plc, most recently as the Vice President and Neuroscience Therapeutic Area Head of Global Clinical Development. From 1996 to 2004, Dr. Whitaker held the positions of Associate Director, Director, and Senior Director of Clinical Research and Development for the Neuroscience Divisions at Wyeth Pharmaceuticals. From 1988 to 1996, he held a variety of teaching and clinical appointments at the University of Vermont College of Medicine and the Medical Center Hospital of Vermont, including Associate Professor of Psychiatry and Director of the Psychopharmacology Clinic. He holds an M.D. from Wake Forest University School of Medicine in Winston-Salem, N.C. and a B.A from Duke University.

Larry Benedict
Executive Vice President and Principal Accounting Officer
Mr. Benedict joined Alder in 2008 and has served as our Executive Vice President and Principal Accounting Officer since October 2016.Since joining Alder, Mr. Benedict has held increasing financial leadership roles including Vice President of Finance and, most recently, Senior Vice President of Finance. From 2000 to 2008, Mr. Benedict served in various positions at Seattle Genetics, Inc., a publicly traded biotechnology company, most recently as Director of Finance and Controller. From 1998 to 2000, Mr. Benedict served as Chief Financial Officer at Sensible Solutions, Inc., a financial software consulting company. From 1997 to 1998, Mr. Benedict served as Finance Manager at SmithKline Beecham Clinical Laboratories, now Quest Diagnostics Incorporated. From 1990 to 1997, he held various finance roles at Bristol-Myers Squibb Company, a biopharmaceutical company. Mr. Benedict holds a B.S. in Accounting from Central Washington University.
Nancy L. Boman, M.D., Ph.D.
Senior Vice President of Regulatory Affairs and Pharmacovigilance
Dr. Boman has served as our Senior Vice President of Regulatory Affairs and Pharmacovigilance since September 2016.From 2010 to 2016, Dr. Boman served as the Senior Vice President of Clinical Development and Regulatory Affairs at CTI BIopharma, a biopharmaceutical company focused on novel targeted therapies for blood-related cancers. She had previously held the positions of Vice President of Clinical Development and Regulatory Affairs at CTI Biopharma and Vice President of Clinical Development and Regulatory Affairs at Acucela. Dr. Boman previously held senior clinical development and regulatory affairs positions at Genentech, Amgen and QLT. Dr. Boman holds a Ph.D. in Biochemistry, an M.D., and a B.S. from the University of British Columbia in Vancouver.
James B. Bucher, J.D. 
Senior Vice President and General Counsel
Mr. Bucher has served as our Senior Vice President and General Counsel since January 2016.Prior to joining Alder BioPharmaceuticals, Mr. Bucher served as Vice President, Corporate Legal Affairs and Secretary, and as the Corporate Compliance Officer, of Exelixis, Inc., a Nasdaq-listed biopharmaceutical company, which he joined in 2007. From 1991 to 2007, Mr. Bucher practiced as a corporate attorney at the international law firm Shearman & Sterling LLP, becoming a partner in 2001. Mr. Bucher holds a J.D. with distinction from Emory University School of Law, and a B.A. in Biology from Colgate University.

Randy Hassler
 Senior Vice President, Pharmaceutical Operations
Mr. Hassler has served as our Senior Vice President of Pharmaceutical Operations since August 2014.Prior to joining Alder BioPharmaceuticals, Mr. Hassler served as Vice President of Operations and Finance and Chief Operating Officer for seven years at Seattle Biomedical Research Institute, working on the fight against global infectious diseases. From 1995 to 2007, he served in various leadership positions at Amgen including Process Development, Quality Control, and Quality Assurance. In addition, he also played major roles in Amgen’s acquisitions of both Immunex and Abgenix. From 1983 to 1995, Mr. Hassler served in a variety of research and development positions at Synergen in Boulder, Colorado. Mr. Hassler holds a B.S. in Microbiology from Indiana University and an M.S. in Microbiology from Colorado State University.
Annette Vahratian
Senior Vice President, Quality
Ms. Vahratian has served as our Senior Vice President of Quality since 2017.
Prior to joining Alder as Vice President, Quality in 2015, Ms. Vahratian served as Principal Quality Consultant for ten years at AV BioPharma Consulting, serving the greater biopharmaceutical industry in support of innovator biologics drug development and regulatory product registrations. While at Immunex Corporation (now Amgen) from 1989 to 2002, Ms. Vahratian served as VP, Quality and various management positions, where she was instrumental in gaining FDA approval of Enbrel® and managing Enbrel® commercial operations at multiple sites worldwide. Ms. Vahratian supported Wyeth (now Pfizer) in their international registration of Enbrel® in the European Union. Ms. Vahratian has been involved in more than 15 IND applications and two FDA marketing authorization drug approvals. Ms. Vahratian holds a B.S. in Biology and Psychology from Hope College.




Overview
Mission
Leadership Team
Board of Directors
Scientific Advisors
History
  

 









            
                                
            Menu                
                        
        
About Us

Overview
Mission
Leadership Team
Board of Directors
Scientific Advisors
History


Research and Development

Pipeline
Technologies
Clinical Trials


Media

In the News
Press Releases


Investors

Investors
Press Releases
Events & Presentations
Financials & Filings
Corporate Governance
Stock Information
Analyst Coverage
Investor FAQS
Shareholder Briefcase
Email Alerts Subscription
Contact Us


Careers

Careers
Current Openings


Contact







×


















ALDR Randall C. Schatzman Insider Trades for Alder BioPharmaceuticals Inc.


































Bulletin






Investor Alert







New York Markets Close in:



Market Snapshot
Winners and Losers


















Expand
Keep Open
Close






Expand
Keep Open
Close






Expand
Keep Open
Close






Expand
Keep Open
Close






Expand
Keep Open
Close































Alder BioPharmaceuticals Inc.

                  NASDAQ: ALDR
          



GO



Set Alerts
Find a Broker




Join TD Ameritrade




Market Index


 

Overview
      
Profile
      
News
      
Charts
      
Financials
      
Historical Quotes
      
Analyst Estimates
      
Options
      
SEC Filings
      
Insiders
      


/marketstate/country/us

Alder BioPharmaceuticals Inc.



Market open
 --Real time quotes
Jul 28, 2017, 2:08 p.m.


ALDR

/quotes/zigman/31444495/composite


$
11.03




Change

+0.38
+3.52%

Volume
Volume 635,009
Real time quotes








/quotes/zigman/31444495/composite
Previous close

$
			10.65
		


$
				11.03
			
Change

+0.38
+3.52%





Day low
Day high
$10.55
$11.25










52 week low
52 week high

            $10.05
        

            $36.48
        


















Insider Activity


Individual




Randall C. Schatzman



Dr. Randall C. Schatzman is President, Chief Executive Officer & Director at Alder Biopharmaceuticals, Inc. and a Manager at Alderbio Holdings LLC. He is on the Board of Directors at Alder Biopharmaceuticals, Inc.
Dr. Schatzman was previously employed as a Director-Gene Discovery by Mercator Genetics, Inc., a Principal by Syntex, Inc., and Senior Vice President-Discovery Research by Celltech R&D, Inc.
He received his undergraduate degree from Purdue University and a doctorate degree from Emory University.



Transactions


Date
Shares
Transaction
Value





02/09/2017
30,000


 
Disposition at $25.03 per share.


750,900


02/09/2017
30,000


 
Derivative/Non-derivative trans. at $1.65 per share.


49,500


11/30/2016
404


 
Award at $20.2 per share.


8,160


11/07/2016
10,000


 
Disposition at $25.16 per share.


251,600


11/07/2016
10,000


 
Derivative/Non-derivative trans. at $1.65 per share.


16,500


10/03/2016
2,700


 
Disposition at $31.55 per share.


85,185


10/03/2016
5,481


 
Disposition at $30.95 per share.


169,637


10/03/2016
8,181


 
Derivative/Non-derivative trans. at $1.26 per share.


10,308


09/01/2016
10,000


 
Disposition at $32.48 per share.


324,800


09/01/2016
10,000


 
Derivative/Non-derivative trans. at $1.26 per share.


12,600


08/01/2016
16


 
Disposition at $32.69 per share.


524


08/01/2016
4,816


 
Disposition at $31.68 per share.


152,571


08/01/2016
5,168


 
Disposition at $30.65 per share.


158,400


08/01/2016
10,000


 
Derivative/Non-derivative trans. at $1.26 per share.


12,600


07/25/2016
10,000


 
Disposition at $28.08 per share.


280,800


07/25/2016
10,000


 
Derivative/Non-derivative trans. at $1.26 per share.


12,600


06/01/2016
1,965


 
Disposition at $30.26 per share.


59,461


06/01/2016
8,035


 
Disposition at $29.51 per share.


237,113


06/01/2016
10,000


 
Derivative/Non-derivative trans. at $1.26 per share.


12,600


05/24/2016
4,017


 
Disposition at $28.03 per share.


112,597


05/24/2016
4,017


 
Derivative/Non-derivative trans. at $1.26 per share.


5,061


05/23/2016
2,997


 
Disposition at $28.01 per share.


83,946


05/23/2016
2,997


 
Derivative/Non-derivative trans. at $1.26 per share.


3,776


05/20/2016
2,986


 
Disposition at $28.01 per share.


83,638


05/20/2016
2,986


 
Derivative/Non-derivative trans. at $1.26 per share.


3,762


04/18/2016
4,514


 
Disposition at $28.08 per share.


126,754


04/18/2016
4,514


 
Derivative/Non-derivative trans. at $1.26 per share.


5,687


04/15/2016
14,024


 
Disposition at $28.11 per share.


394,215


04/15/2016
5,486


 
Derivative/Non-derivative trans. at $1.26 per share.


6,912


04/15/2016
8,538


 
Derivative/Non-derivative trans. at $0.38 per share.


3,244


04/14/2016
11,462


 
Disposition at $28.01 per share.


321,051


04/14/2016
11,462


 
Derivative/Non-derivative trans. at $0.38 per share.


4,355


01/04/2016
2,020


 
Disposition at $31.95 per share.


64,539


01/04/2016
7,980


 
Disposition at $31.35 per share.


250,173


01/04/2016
10,000


 
Derivative/Non-derivative trans. at $0.39 per share.


3,900


12/01/2015
10,000


 
Disposition at $37.24 per share.


372,400


12/01/2015
10,000


 
Derivative/Non-derivative trans. at $0.39 per share.


3,900


11/02/2015
5,222


 
Disposition at $34.44 per share.


179,846


11/02/2015
1,400


 
Disposition at $33.4 per share.


46,760


11/02/2015
3,378


 
Disposition at $32.7 per share.


110,461


11/02/2015
10,000


 
Derivative/Non-derivative trans. at $0.39 per share.


3,900


05/26/2015
50,000


 
Disposition at $38.96 per share.


1,948,000


05/26/2015
50,000


 
Derivative/Non-derivative trans. at $0.39 per share.


19,500


01/27/2015
63,578


 
Disposition at $28.71 per share.


1,825,325


01/26/2015
36,422


 
Disposition at $27.93 per share.


1,017,267





        Copyright 2017 FactSet Research Systems Inc. All rights reserved. Source FactSet Fundamentals.
    











            Officers and Executives
        





Dr. Randall C. Schatzman 
President, Chief Executive Officer & Director




Dr. Timothy  Whitaker 
Chief Medical Officer




Dr. John A. Latham 
Chief Scientific Officer




Mr. Annette  Vahratian 
Senior Vice President-Quality




Dr. Nancy L. Boman 
Senior Vice President-Regulatory Affairs




Ms. Elisabeth A. Sandoval 
Chief Commercial Officer




Mr. David A. Walsey 
Investor Relations Contact




Dr. Jeffrey T. L. Smith 
Senior Vice President-Translational Medicine




Ms. Wendy L. Yarno 
Director




Mr. Paul R. Carter 
Director




Mr. Paul B. Cleveland 
Director




Dr. Mark J. Litton 
Secretary, Treasurer & Chief Business Officer




Mr. Larry  Benedict 
Chief Accounting Officer & Executive VP




Mr. James B. Bucher 
Senior Vice President & General Counsel




Mr. Stephen M. Dow 
Chairman




Dr. Clay B. Siegall 
Independent Director




Dr. Alan B. Montgomery 
Independent Director




Dr. Deepa R. Pakianathan 
Independent Director




Dr. Heather Elizabeth Preston 
Independent Director









Trending Tickers


/quotes/zigman/17636479/composite VUZI+15.60%


/quotes/zigman/237947/composite JCP-5.83%


/quotes/zigman/59392505/composite NUGT-2.93%


/quotes/zigman/59386294/composite JNUG-5.94%


/quotes/zigman/65801738/composite TLT+1.11%


X




Powered by














Log In




2:09 PM EDT
July 28, 2017


/marketstate/country/us
New York

	Open


/marketstate/country/uk
London

	Closed


/marketstate/country/jp
Tokyo

	Closed





/marketstate/country/us
 


/marketstate/country/uk
 


/marketstate/country/jp
 











View All



Latest News

/news/latest
2:07p101 things to do in London for $20 or less
2:05pWho are the beneficiaries of a 401(k) if my wife and I die at the same time?
2:04pCharlie Gard, British baby at center of controversy, has died
2:03pUnder Armour's stock's low price doesn't mean it is cheap
2:00pRetirement Weekly news and analysis
1:56pFloyd Mayweather says he is going to make bank off an ICO
1:54pFoxconn’s history of broken promises casts a shadow on Wisconsin news
1:52pGoodyear stock stumbles 11% after quarter ‘played out differently than we expected’
1:49pThis city’s subway system will soon run mostly on renewable energy
1:48pWhich state’s 529 plan is right for you?
1:45pWhy so many teens are clueless about money
1:45pHere’s something that can improve your memory — and help you sleep
1:44pGold marks highest finish since mid-June, up 1.1% for the week
1:40pHow your pet could make you a target for scammers
1:39pOil sets sights on biggest weekly gain of the year
1:38pAugust gold climbs $8.40, or 0.7%, to settle at $1,268.40.oz
1:38pGold prices log highest finish since mid-June, up 1.1% for the week
1:34pStitch Fix has confidentially filed to go public: report
1:32pCan China make the reflation trade great again?
1:31pGet ready for the less-profitable Amazon that you used to know 
Loading more headlines...




dow

/quotes/zigman/627449/realtime
21,805.36

+8.81
+0.04%





nasdaq

/quotes/zigman/12633936/realtime
6,375.71

-6.47
-0.10%





s&p 500

/quotes/zigman/3870025/realtime
2,469.45

-5.97
-0.24%













Kiosk


1352872800000
1352872800000


The RetireMentors






				Retirement advice from our industry experts
				Our team of financial professionals can help you plan and save 
					for retirement, then 
				live well in it.



/conga/kiosk/retirementors.html
361307




1320411600000
1320616500000


Alerts



/conga/kiosk/alerts.html
310238




1333717800000
1333964100000


Virtual Stock Exchange





Our free stock-market game
				• Trade your virtual portfolio in real time
				• Talk strategies in group discussions
				• Find or create a game that suits you
				• Use our learning center to improve 



/conga/kiosk/games.html
310284




1245657600000
1277280000000


Location Scouts




Housing-market insights from our realty pros
																																																							Plus the latest data from Realtor.com on 21 home markets across the U.S.
• See our complete Real Estate site


/conga/kiosk/real_estate.html
357012




1404799200000
1404799200000


Lazy Portfolios





				Set it and forget it
				Check out the returns on our 8 Lazy Portfolios that are made up 
				of low-cost 
				buy-and-hold index funds.

				• How to create your own Lazy Portfolio


/conga/kiosk/lazy_portfolio.html
313134














MarketWatch.com




Site Index
Topics
Help
Feedback
Newsroom Roster

                    Media Archive
Premium Products
Mobile


Company Info
Code of Conduct
Corrections
Advertising Media Kit
Advertise Locally
Reprints & Licensing
Broker Center

                    Your Ad Choices


Follow MarketWatch


































RSS
Podcasts






WSJ.com
Barron's Online
BigCharts
Virtual Stock Exchange


Financial News London
WSJ.com Small Business
realtor.com
Mansion Global












		Copyright © 2017 MarketWatch, Inc.  All rights reserved.
		By using this site, you agree to the Terms of Service,
        Privacy Policy and Cookie Policy.
	



            Intraday Data provided by SIX Financial Information and subject to terms of use. Historical and current end-of-day data provided by SIX Financial Information. All quotes are in local exchange time. Real-time last sale data for U.S. stock quotes reflect trades reported through Nasdaq only. Intraday data delayed at least 15 minutes or per exchange requirements.
        






MarketWatch Top Stories
Link to MarketWatch's Slice.

15






















































 




Leadership Team - Alder Biopharmaceuticals



































 























 
Leadership Team






Leadership Team





Randall C. Schatzman, Ph.D.
President and Chief Executive Officer
Dr. Schatzman has served as our President, Chief Executive Officer and director since he co-founded the company, which commenced operations in January 2004. From 1999 to 2004, Dr. Schatzman served as Senior Vice President of Discovery Research at Celltech R&D, Inc., a wholly owned subsidiary of Celltech Group plc, a biopharmaceutical company, where he led a group of scientists responsible for much of the therapeutic antibody pipeline for Celltech. From 1995 to 1999, Dr. Schatzman served as Director of Gene Discovery at Mercator Genetics Inc., a genomics company. From 1987 to 1995, Dr. Schatzman served as Section Leader at Roche Bioscience, previously Syntex Corp., a subsidiary of Roche Holdings Ltd., a biotechnology company, where he helped found the Cancer and Developmental Biology Institute. Dr. Schatzman holds a Ph.D. in Molecular Pharmacology from Emory University and a B.S. in Biochemistry from Purdue University.

John A. Latham, Ph.D.
Chief Scientific Officer
Dr. Latham has served as our Chief Scientific Officer since co-founding Alder BioPharmaceuticals in January 2004.From 1998 to 2004, Dr. Latham served as a director, senior director, and most recently as Vice President of Gene Function and Target Validation for Celltech Group plc. In 1994, Dr. Latham joined Darwin Molecular Corporation, a first-generation gene-to-drug biotechnology company, as a founding director, where he served from 1994 to 1998. Dr. Latham was one of the early scientists hired by Gilead Sciences, Inc., a biopharmaceutical company, and, from 1989 to 1994, he was a member of a core group established to exploit novel oligonucleotide-based technologies. Dr. Latham holds a Ph.D. in Biochemistry from Massachusetts Institute of Technology and a B.S. in Chemistry from Colorado State University.

Mark J. Litton, Ph.D., MBA
Chief Business Officer and Treasurer
Dr. Litton has served as our Chief Business Officer, Treasurer and Secretary since co-founding the company in January 2004. From 1999 to 2004, Dr. Litton served as Vice President of Business Development for Celltech Group, where he was responsible for securing, commercializing and partnering numerous novel discoveries and therapeutic opportunities. In 1999, Dr. Litton joined Celltech Group as an employee of Chiroscience Group plc and was later promoted to Vice President Business Development after Chiroscience’s merger with Celltech Group in 1999. From 1997 to 1999, Dr. Litton served as the Manager of Business Development for Ribozyme Pharmaceuticals Inc., currently Sirna Therapeutics, Inc., a biopharmaceutical company, where he helped form relationships with Eli Lilly and Company, Roche Bioscience and GlaxoWellcome plc, currently GlaxoSmithKline plc, a biopharmaceutical company. From 1991 to 1994, Dr. Litton served as a research associate for DNAX Research Institute, a research facility of Schering-Plough, now Merck & Co., a publicly traded pharmaceutical company. Dr. Litton holds a Ph.D. in Immunology from Stockholm University, an M.B.A. from Santa Clara University and a B.S. in Biochemistry from the University of California, Santa Cruz.

Jeffrey T.L. Smith, M.D., FRCP
Senior Vice President, Translational Medicine
Dr. Smith has served as our Senior Vice President, Translational Medicine since 2012 and served in other senior management positions from April 2004 to 2012.From 1999 to 2004, Dr. Smith served as Senior Director of Medical Research for Celltech R&D, where he was responsible for planning and managing the CDP870 anti-TNF clinical trials for RA as well as several other key autoimmune clinical development programs. From 1997 to 1999, Dr. Smith served as Medical Director at Simbec Research Ltd., a contract research organization. From 1995 to 1997, Dr. Smith served as Head of Clinical Pharmacology at Hoechst Marion Roussel Ltd., a pharmaceutical company. From 1994 to 1995, Dr. Smith served as a Senior Clinical Physician at the Proctor and Gamble Company, a publicly-traded consumer products company, and from 1989 to 1994, he served as a Senior Research Physician in the clinical pharmacology department at Glaxo Research and Development Ltd., now a division of GlaxoSmithKline plc, a healthcare company. Dr. Smith holds an M.D. from the University of London and is a Fellow of the Royal College of Physicians in London.
Elisabeth A. Sandoval, MBA
Chief Commercial Officer
Ms. Sandoval has served as our Chief Commercial Officer since September 2016.From 2012 to 2015, Ms. Sandoval served as the Chief Commercial Officer for Kythera Biopharmaceuticals. From 2010 to 2012, she served as Vice President of Global Marketing and Strategy at Bausch + Lomb Surgical. From 1988 to 2010, she held roles of increasing responsibility at Allergan including Global Vice President, Strategic Marketing and Senior Director of Global Strategic Marketing, which included sales management and marketing leadership for multiple products including Botox® for neurological and other disorders. She began her career in research and development at Johnson & Johnson’s Ethicon division. She holds an MBA from Pepperdine University and a B.S. in Biology from the University of California, Irvine.
Timothy M. Whitaker, M.D. 
Chief Medical Officer
Dr. Whitaker has served as our Chief Medical Officer since June 2016.From 2004 to 2016, Dr. Whitaker held positions of increasing responsibility at Shire Plc, most recently as the Vice President and Neuroscience Therapeutic Area Head of Global Clinical Development. From 1996 to 2004, Dr. Whitaker held the positions of Associate Director, Director, and Senior Director of Clinical Research and Development for the Neuroscience Divisions at Wyeth Pharmaceuticals. From 1988 to 1996, he held a variety of teaching and clinical appointments at the University of Vermont College of Medicine and the Medical Center Hospital of Vermont, including Associate Professor of Psychiatry and Director of the Psychopharmacology Clinic. He holds an M.D. from Wake Forest University School of Medicine in Winston-Salem, N.C. and a B.A from Duke University.

Larry Benedict
Executive Vice President and Principal Accounting Officer
Mr. Benedict joined Alder in 2008 and has served as our Executive Vice President and Principal Accounting Officer since October 2016.Since joining Alder, Mr. Benedict has held increasing financial leadership roles including Vice President of Finance and, most recently, Senior Vice President of Finance. From 2000 to 2008, Mr. Benedict served in various positions at Seattle Genetics, Inc., a publicly traded biotechnology company, most recently as Director of Finance and Controller. From 1998 to 2000, Mr. Benedict served as Chief Financial Officer at Sensible Solutions, Inc., a financial software consulting company. From 1997 to 1998, Mr. Benedict served as Finance Manager at SmithKline Beecham Clinical Laboratories, now Quest Diagnostics Incorporated. From 1990 to 1997, he held various finance roles at Bristol-Myers Squibb Company, a biopharmaceutical company. Mr. Benedict holds a B.S. in Accounting from Central Washington University.
Nancy L. Boman, M.D., Ph.D.
Senior Vice President of Regulatory Affairs and Pharmacovigilance
Dr. Boman has served as our Senior Vice President of Regulatory Affairs and Pharmacovigilance since September 2016.From 2010 to 2016, Dr. Boman served as the Senior Vice President of Clinical Development and Regulatory Affairs at CTI BIopharma, a biopharmaceutical company focused on novel targeted therapies for blood-related cancers. She had previously held the positions of Vice President of Clinical Development and Regulatory Affairs at CTI Biopharma and Vice President of Clinical Development and Regulatory Affairs at Acucela. Dr. Boman previously held senior clinical development and regulatory affairs positions at Genentech, Amgen and QLT. Dr. Boman holds a Ph.D. in Biochemistry, an M.D., and a B.S. from the University of British Columbia in Vancouver.
James B. Bucher, J.D. 
Senior Vice President and General Counsel
Mr. Bucher has served as our Senior Vice President and General Counsel since January 2016.Prior to joining Alder BioPharmaceuticals, Mr. Bucher served as Vice President, Corporate Legal Affairs and Secretary, and as the Corporate Compliance Officer, of Exelixis, Inc., a Nasdaq-listed biopharmaceutical company, which he joined in 2007. From 1991 to 2007, Mr. Bucher practiced as a corporate attorney at the international law firm Shearman & Sterling LLP, becoming a partner in 2001. Mr. Bucher holds a J.D. with distinction from Emory University School of Law, and a B.A. in Biology from Colgate University.

Randy Hassler
 Senior Vice President, Pharmaceutical Operations
Mr. Hassler has served as our Senior Vice President of Pharmaceutical Operations since August 2014.Prior to joining Alder BioPharmaceuticals, Mr. Hassler served as Vice President of Operations and Finance and Chief Operating Officer for seven years at Seattle Biomedical Research Institute, working on the fight against global infectious diseases. From 1995 to 2007, he served in various leadership positions at Amgen including Process Development, Quality Control, and Quality Assurance. In addition, he also played major roles in Amgen’s acquisitions of both Immunex and Abgenix. From 1983 to 1995, Mr. Hassler served in a variety of research and development positions at Synergen in Boulder, Colorado. Mr. Hassler holds a B.S. in Microbiology from Indiana University and an M.S. in Microbiology from Colorado State University.
Annette Vahratian
Senior Vice President, Quality
Ms. Vahratian has served as our Senior Vice President of Quality since 2017.
Prior to joining Alder as Vice President, Quality in 2015, Ms. Vahratian served as Principal Quality Consultant for ten years at AV BioPharma Consulting, serving the greater biopharmaceutical industry in support of innovator biologics drug development and regulatory product registrations. While at Immunex Corporation (now Amgen) from 1989 to 2002, Ms. Vahratian served as VP, Quality and various management positions, where she was instrumental in gaining FDA approval of Enbrel® and managing Enbrel® commercial operations at multiple sites worldwide. Ms. Vahratian supported Wyeth (now Pfizer) in their international registration of Enbrel® in the European Union. Ms. Vahratian has been involved in more than 15 IND applications and two FDA marketing authorization drug approvals. Ms. Vahratian holds a B.S. in Biology and Psychology from Hope College.




Overview
Mission
Leadership Team
Board of Directors
Scientific Advisors
History
  

 









            
                                
            Menu                
                        
        
About Us

Overview
Mission
Leadership Team
Board of Directors
Scientific Advisors
History


Research and Development

Pipeline
Technologies
Clinical Trials


Media

In the News
Press Releases


Investors

Investors
Press Releases
Events & Presentations
Financials & Filings
Corporate Governance
Stock Information
Analyst Coverage
Investor FAQS
Shareholder Briefcase
Email Alerts Subscription
Contact Us


Careers

Careers
Current Openings


Contact







×


















Microsoft personalized ad preferences




 













To opt out of personalized ads in this browser, your browser history must allow first-party and third-party cookies and you must have your browsing experience set to NOT delete browsing history on exit. Instructions for enabling cookies and configuring your browsing history may be available in your browsers settings, privacy, or help documentation.

















Sign in
















  Hold on… We’re sorry but this didn’t work.                  You can’t turn off personalized ads right now because your browser is currently blocking third-party cookies. We can help you fix this issue.                Let’s get started:  Depending on what browser you use, open Options or Settings.                  Make sure that third-party cookies are not blocked anymore. To find out how, search your browser’s Help.                                 Revisit http://choice.microsoft.com/opt-out, and then on the “Personalized ads in this browser” tile, click Off.                 ext74081 




  About Our Ads To create a more customized online experience, some of the ads you may receive on Microsoft websites and apps are tailored to your previous activities, searches and site visits. You're in control and here's where you can make the advertising choice that's right for you. ext74075 




  Where Can I Learn More about Advertising on Microsoft Websites and Apps? Microsoft partners with Oath, AppNexus and other third party service providers to help present customized content and display advertisements on MSN, Outlook.com and other websites and apps. Microsoft also delivers search ads to Bing and our search syndication partners. Learn more about Microsoft’s privacy practices here. You can learn more about interest-based ads from Oath and AppNexus in their privacy statements: Oath and AppNexus. What Choices Do I Have About Interest-Based Advertising? On this page, you can opt out of receiving interest based advertising from Microsoft. You can also opt out of receiving interest-based advertising from all self-regulatory members, including Microsoft, Oath, AppNexus and other third party ad networks, at the following sites:  In the US: Digital Advertising Alliance (DAA) In Europe: European Interactive Digital Advertising Alliance (EDAA) In Canada: Ad Choices: Digital Advertising Alliance of Canada (DAAC)  You can control interest-based advertising in Windows apps by turning off the advertising ID in Windows Settings.  More choices  Do you want personalized ads from other companies?  Questions? If you have a privacy question or a question for the Chief Privacy Officer of Microsoft, please contact us by using our web form. We will respond to questions within 30 days. ext74076 




       Personalized ads in this browser     OFF    Opt-out is currently unavailable, please try again later.  Control the "personalized ads" setting for this web browser.  Learn more           If you want Microsoft to show ads that might be relevant to you, click On. To show “generic” ads, click Off.          ext74078 




       Personalized ads wherever I use my Microsoft account     OFF   Sign in to change...    Opt-out is currently unavailable, please try again later.  Control the "personalized ads" setting that applies when you are signed in on any computer or device with your Microsoft account, including Windows, Windows phone, Xbox and other devices.  Learn more                    If you want Microsoft to show ads that might be relevant to you, click On. To show “generic” ads, click Off.         If you choose “generic” ads and use a browser, your choice applies to everyone when using that browser as long as you do not clear your cookies.          ext74079 




       Personalized ads in Windows         In your Windows Settings, you can turn off personalized ads that appear in apps on this device. You’ll still see ads, but they won’t be personalized anymore.     If you have Windows 8.1:            Access the charms by touching or moving your pointer to the right edge of the screen.                 Click or tap Settings, and then click or tap Change PC Settings.                 Click or tap Privacy, and then turn off Let apps use my advertising ID for experiences across apps.          If you have Windows 10:            Click or tap the Start button.                 Click or tap Settings.                 Click or tap Privacy, and then turn off Let apps use my advertising ID for experiences across apps.          If you have a Windows mobile device:            Go to Settings.                 Tap on Privacy.                 Tap on Advertising ID, and then turn off Let apps use my advertising ID for experiences across apps.                If you want to turn off personalized ads from Microsoft wherever you use your Microsoft account including apps on Windows, Windows Phone, Xbox and other devices, you can do so by selecting the Microsoft account option above.    ext74080 














Legal
Privacy & Cookies
© 2017 Microsoft









